Literature DB >> 14039629

New antibiotics, ilamycins.

T TAKITA, K OHI, Y OKAMI, K MAEDA, H UMEZAWA.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/chemistry

Mesh：

Substances：

Year:  1962        PMID： 14039629

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  10 in total

1.  Identification and characterization of a bacterial cytochrome P450 monooxygenase catalyzing the 3-nitration of tyrosine in rufomycin biosynthesis.

Authors:  Hiroya Tomita; Yohei Katsuyama; Hiromichi Minami; Yasuo Ohnishi
Journal:  J Biol Chem       Date:  2017-08-03       Impact factor: 5.157

Review 2.  New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.

Authors:  Masayuki Igarashi; Yoshimasa Ishizaki; Yoshiaki Takahashi
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

3.  Antimycobacterial Rufomycin Analogues from Streptomyces atratus Strain MJM3502.

Authors:  Bin Zhou; Gauri Shetye; Yang Yu; Bernard D Santarsiero; Larry L Klein; Cele Abad-Zapatero; Nina M Wolf; Jinhua Cheng; Yingyu Jin; Hanki Lee; Joo-Won Suh; Hyun Lee; Jonathan Bisson; James B McAlpine; Shao-Nong Chen; Sang-Hyun Cho; Scott G Franzblau; Guido F Pauli
Journal:  J Nat Prod       Date:  2020-02-07       Impact factor: 4.050

4.  Rufomycins or Ilamycins: Naming Clarifications and Definitive Structural Assignments.

Authors:  Bin Zhou; Prabhakar S Achanta; Gauri Shetye; Shao-Nong Chen; Hyun Lee; Ying-Yu Jin; Jinhua Cheng; Mi-Jin Lee; Joo-Won Suh; Sanghyun Cho; Scott G Franzblau; Guido F Pauli; James B McAlpine
Journal:  J Nat Prod       Date:  2021-10-10       Impact factor: 4.050

Review 5.  Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies.

Authors:  Ricardo Ribeiro; Eugénia Pinto; Carla Fernandes; Emília Sousa
Journal:  Mar Drugs       Date:  2022-06-15       Impact factor: 6.085

Review 6.  Bacterial terpenome.

Authors:  Jeffrey D Rudolf; Tyler A Alsup; Baofu Xu; Zining Li
Journal:  Nat Prod Rep       Date:  2021-05-26       Impact factor: 15.111

Review 7.  Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening.

Authors:  Edyta M Grzelak; Mary P Choules; Wei Gao; Geping Cai; Baojie Wan; Yuehong Wang; James B McAlpine; Jinhua Cheng; Yingyu Jin; Hanki Lee; Joo-Won Suh; Guido F Pauli; Scott G Franzblau; Birgit U Jaki; Sanghyun Cho
Journal:  J Antibiot (Tokyo)       Date:  2019-07-11       Impact factor: 2.649

8.  Characterization of Regulatory and Transporter Genes in the Biosynthesis of Anti-Tuberculosis Ilamycins and Production in a Heterologous Host.

Authors:  Jianqiao He; Xin Wei; Zhijie Yang; Yan Li; Jianhua Ju; Junying Ma
Journal:  Mar Drugs       Date:  2020-04-17       Impact factor: 5.118

Review 9.  Recent Developments on the Synthesis and Bioactivity of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides That Demonstrate Anti-Malaria and Anti-Tuberculosis Activity.

Authors:  Uli Kazmaier; Lukas Junk
Journal:  Mar Drugs       Date:  2021-08-03       Impact factor: 5.118

10.  Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents.

Authors:  Junying Ma; Hongbo Huang; Yunchang Xie; Zhiyong Liu; Jin Zhao; Chunyan Zhang; Yanxi Jia; Yun Zhang; Hua Zhang; Tianyu Zhang; Jianhua Ju
Journal:  Nat Commun       Date:  2017-08-30       Impact factor: 14.919
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.